Author

Eloise Clarkson

Brunel University of LondonORCID 0009-0004-4740-0498Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Annabelle LewisiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

1 paper

Recent·Most cited

Cancer BiologyMolecular OncologyPeer-reviewedMay 28, 2025

BMP antagonist CHRDL2 enhances the cancer stem cell phenotype and increases chemotherapy resistance in Colorectal Cancer

Eloise Clarkson, Annabelle Lewis

This study shows that CHRDL2 overexpression in CRC cells enhances chemotherapy resistance and stem-cell properties by boosting DNA repair and WNT signaling.

6 citations

humanbulk RNA-seq

𝕏 PostBluesky